Thank You! More Brews in 2014
Thank you to all of our brewers and their patrons for making the 2013 Ales for ALS™ a success! On behalf of the Smith, Hanses and Reich families, thank you each for your support. 2014 Ales for ALS™ brewers will be confirmed this spring and beers will be available this summer.
Brewery's John Mallet and Sierra Nevada's Ken Grossman
Loftus Ranches and Hopunion have created Ales for ALS to support a very worthy cause – ALS research. They have offered participating brewers access to a proprietary hop blend, free of charge, in exchange for participation in Ales for ALS™. While we would like to work with every brewer in the United States (that would really raise a lot of research funding!) we are limited by the hop blend supply. Participating brewers receive an invitation from Loftus Ranches and Hopunion. Each will brew special beers with these hops and will donate a portion of the sales to ALS TDI, the world's leader in ALS research.
What is ALS? (AKA: Lou Gehrig's Disease)
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) is a progressive neurodegenerative disease that leads to
due to the death of motor neurons in the spinal cord and brain.
- There is no known cure for the disease.
- The average person survives only 2-5 years following diagnosis.
- About 5,000 people in the US are diagnosed with ALS each year.
- There are about 30,000 people in the US diagnosed with ALS today.
- The worldwide population of ALS patients is estimated at 450,000.
About ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) is the world's leading ALS research organization and aims to discover and develop effective treatments and a cure for ALS. Built by and for patients, the Cambridge, MA based drug development institute operates as a 501c3 nonprofit: combining the optimal entrepreneurial practices of a biotechnology and pharmaceutical company with the passion and urgency of a nonprofit mission. For more information, please visit us online at www.als.net.